Former Lawyer Went From $50K To $5.3M Trading Options
Slaving away for 70 hrs a week as a lawyer in Chicago, I was miserable.

I ran into guys who worked the trading floor at the local exchange. I began trading the same way they did. I started out with $50K (much more than I needed, actually).

I grew my $50K into $5.3M
I'll show you how I did it here.

SCLP Insider Trading (Scancell)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): £106,000
Insider Selling (Last 12 Months): £499,999.92

Scancell Insider Trading History Chart

This chart shows the insider buying and selling history at Scancell by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Scancell Share Price & Price History

Current Price: GBX 13
Price Change: Price Decrease of -0.125 (-0.95%)
As of 06/30/2022 05:22 PM ET

This chart shows the closing price history over time for SCLP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.
Download your FREE Options Strategy Guide Today.

Scancell Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/2/2022Martin DiggleInsiderBuy250,000GBX 12£30,000
11/2/2021Martin DiggleInsiderBuy200,000GBX 19£38,000
9/9/2021Lindy DurrantInsiderSell2,380,952GBX 21£499,999.92
7/29/2021Martin DiggleInsiderBuy200,000GBX 19£38,000
6/4/2021Martin DiggleInsiderBuy350,000GBX 19£66,500
4/29/2021Martin DiggleInsiderBuy400,000GBX 20£80,000
2/18/2021Martin DiggleInsiderSell200,000GBX 28£56,000
2/16/2021Martin DiggleInsiderSell400,000GBX 24£96,000
12/14/2020Martin DiggleInsiderBuy750,000GBX 11£82,500
11/24/2020Cliff HollowayInsiderBuy100,000GBX 11£11,000
4/27/2020Martin DiggleInsiderSell1,500,000GBX 8£120,000
12/16/2019Martin DiggleInsiderBuy2,925,000GBX 5£146,250
See Full Table
Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.
Download your FREE Options Strategy Guide Today.

SEC Filings (Institutional Ownership Changes) for Scancell (LON:SCLP)

Scancell logo
Scancell Holdings plc, a clinical stage biopharmaceutical company, engages in the discovery and development of novel vaccines and antibody medicines to treat unmet needs in cancer and infectious diseases. The company's product candidates include SCIB1, which is in phase II clinical trial for the treatment of metastatic melanoma; SCIB2 for the treatment of non-small cell lung cancer; and Modi-1 that is in phase I/II clinical trials for the treatment of head and neck, triple negative breast, ovarian, and renal cancers. It also develops Modi-2, which targets homocitrullinated cancer antigens. In addition, the company develops SCOV1 and SCOV2 COVIDITY, a prophylactic DNA vaccine against the SARS-CoV-2 virus. Scancell Holdings plc was founded in 1997 and is based in Oxford, the United Kingdom.
Read More on Scancell

Today's Range

Now: GBX 13
Low: 12.90
High: 13.25

50 Day Range

MA: GBX 13.61
Low: 12.10
High: 16.58

52 Week Range

Now: GBX 13
Low: 10.50
High: 23.90

Volume

236,406 shs

Average Volume

771,383 shs

Market Capitalization

£105.98 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Scancell?

Scancell's top insider shareholders include:
  1. Cliff Holloway (Insider)
  2. Lindy Durrant (Insider)
  3. Martin Diggle (Insider)
Learn More about top insider investors at Scancell.
Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.
Download your FREE Options Strategy Guide Today.